Stichtenoth Guido, Linderholm Bim, Almlén Andreas, Björkman Marie Hägerstrand, Byman Irene, Nordling Kerstin, Robertson Bengt, Johansson Jan, Herting Egbert, Curstedt Tore
Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, Sweden.
Crit Care Med. 2009 May;37(5):1750-6. doi: 10.1097/CCM.0b013e31819fb42c.
Surface activity of pulmonary surfactant is impaired by exposure to syringes lubricated with silicone oil (SO). These syringes are used daily in clinical practice.
In vitro experiments were used for detection of SO, determination of surface activity, and semiquantitative measurement of surfactant protein (SP)-B and -C in SO/surfactant mixtures. Randomized, controlled animal studies were applied for determination of in vivo activity.
University research laboratory.
Mass spectrometry of SO originating from syringes with and without surfactant was performed. The surface activity of SO plus surfactant phospholipids (PLs) or modified natural surfactant (Curosurf) was measured. SO/Curosurf preparations were further analyzed for changes in the content of SP-B and SP-C using immunoblotting. Neonatal rabbits received mixtures of SO/Curosurf (ratio 0-1.3 mg/mg PL) intratracheally and were then ventilated with a standardized sequence of peak insufflation pressures. Tidal volume curves were recorded, gas volumes of excised lungs were measured, and histologic analysis was performed.
Dissolved SO was found after rinsing syringes with organic solvents or Curosurf. Surface activity of Curosurf was significantly reduced after addition of 0.13-1.3 mg SO/mg PL. Immunoblotting revealed interference of SO with SP-B, but not with SP-C. With increasing SO/Curosurf ratios, patchy alveolar air expansion was observed, lung gas volumes were reduced, and time to inflate the lungs was increased, whereas compliance and tidal volumes remained unimpaired.
In vitro SO impairs surface activity of Curosurf and leads to interference with SP-B. SO contamination of exogenous surfactant impairs lung function in animal studies and should be avoided.
接触用硅油(SO)润滑的注射器会损害肺表面活性物质的表面活性。这些注射器在临床实践中每天都会用到。
采用体外实验检测SO、测定表面活性,并对SO/表面活性物质混合物中的表面活性物质蛋白(SP)-B和-C进行半定量测量。采用随机对照动物研究来测定体内活性。
大学研究实验室。
对有无表面活性物质的注射器中的SO进行质谱分析。测量SO加表面活性物质磷脂(PLs)或改良天然表面活性物质(珂立苏)的表面活性。使用免疫印迹法进一步分析SO/珂立苏制剂中SP-B和SP-C含量的变化。新生兔经气管内给予SO/珂立苏混合物(比例为0 - 1.3 mg/mg PL),然后以标准化的峰值吹入压力序列进行通气。记录潮气量曲线,测量离体肺的气体量,并进行组织学分析。
用有机溶剂或珂立苏冲洗注射器后发现有溶解的SO。加入0.13 - 1.3 mg SO/mg PL后,珂立苏的表面活性显著降低。免疫印迹显示SO对SP-B有干扰,但对SP-C没有干扰。随着SO/珂立苏比例的增加,观察到肺泡散在性气体膨胀、肺气体量减少以及肺充气时间增加,而顺应性和潮气量未受影响。
体外实验中SO会损害珂立苏的表面活性并导致对SP-B的干扰。在动物研究中,外源性表面活性物质被SO污染会损害肺功能,应予以避免。